Review Article published in nature reviews immunology
In a recent article published in nature reviews immunology, LIT scientists, Dr. Jeremy G. Baldwin, Dr. Christoph Heuser-Loy, and Prof. Luca Gattinoni, provide an update on the latest advances in our understanding of how organelles govern T-cell function and how this knowledge can be leveraged to improve the therapeutic efficacy of cancer immunotherapies.
ArticleArticle Details
-
Date Published
October 17, 2025
nature reviews immunology is the highest-ranked journal in the field, with a five-year impact factor of 77.6 and a broad readership spanning basic scientists to clinicians. This review will be of particular interest to immunologists, oncologists, and researchers in cellular therapies and immune modulation.
The article offers a comprehensive overview of how organelles — including mitochondria, lysosomes, endoplasmic reticulum, and peroxisomes — power T-cell metabolism, signaling, and persistence during antitumor responses. Importantly, the authors then discuss emerging therapeutic strategies, including organelle-targeted drugs, the use of organelles as delivery systems for therapeutic cargo, and even the transfer of native or synthetic organelles to boost T-cell efficacy.
By revealing how the inner machinery of T cells can be optimized, this review uncovers an exciting new frontier in therapeutic innovation that could significantly enhance immune-checkpoint blockade and adoptive T-cell therapies.
Dr. Jeremy G. Baldwin, Dr. Christoph Heuser-Loy and Prof. Luca Gattinoni (left to right) are the authors of the article in nature reviews immunology.
Explore our Research Division in greater depth!
Get to know our team and find out more about our pioneering research.